| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.165 | 5.019 | 5.989 | 5.531 | 5.540 | 4.403 | 5.921 | 5.639 | 6.122 | 4.493 |
| Total Income - EUR | 3.165 | 5.019 | 5.989 | 5.531 | 5.540 | 4.407 | 5.921 | 5.639 | 6.122 | 4.493 |
| Total Expenses - EUR | 3.276 | 1.773 | 1.182 | 1.628 | 1.183 | 1.239 | 1.679 | 1.606 | 3.231 | 3.303 |
| Gross Profit/Loss - EUR | -110 | 3.247 | 4.807 | 3.904 | 4.357 | 3.168 | 4.242 | 4.034 | 2.890 | 1.190 |
| Net Profit/Loss - EUR | -200 | 3.096 | 4.628 | 3.745 | 4.190 | 3.037 | 4.064 | 3.868 | 2.483 | 1.003 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dacimari-Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 452 | 180 | 118 | 57 | 0 | 0 | 0 | 17.017 | 14.844 | 12.653 |
| Current Assets | 4.336 | 3.032 | 5.044 | 8.334 | 8.841 | 7.570 | 7.473 | 0 | 1 | 370 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4.294 | 3.032 | 5.044 | 8.334 | 8.841 | 7.570 | 7.473 | 0 | 1 | 370 |
| Shareholders Funds | 4.763 | 3.166 | 5.114 | 8.356 | 8.802 | 7.537 | 7.391 | 5.198 | 7.666 | 2.071 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25 | 46 | 48 | 36 | 39 | 33 | 82 | 11.819 | 7.221 | 10.952 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dacimari-Medica Srl